+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lung Cancer"

Precision Oncology Market Report and Forecast 2023-2031 - Product Thumbnail Image

Precision Oncology Market Report and Forecast 2023-2031

  • Report
  • July 2023
  • 140 Pages
  • Global
From
From
From
From
From
Lung Adenocarcinoma Market Report and Forecast 2024-2032 - Product Thumbnail Image

Lung Adenocarcinoma Market Report and Forecast 2024-2032

  • Report
  • May 2024
  • 160 Pages
  • Global
From
Small Cell Lung Cancer (SCLC) Market Report and Forecast 2024-2032 - Product Thumbnail Image

Small Cell Lung Cancer (SCLC) Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Radiation Oncology Market Report and Forecast 2023-2031 - Product Thumbnail Image

Radiation Oncology Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
United States Digital Marketing Trends in Non-small Cell Lung Cancer - Product Thumbnail Image

United States Digital Marketing Trends in Non-small Cell Lung Cancer

  • Report
  • November 2023
  • 31 Pages
  • United States
From
Loading Indicator

Lung cancer is a type of cancer that originates in the lungs. It is the leading cause of cancer-related death worldwide. Oncology is the branch of medicine that deals with the diagnosis, treatment, and prevention of cancer. Lung cancer is one of the most common types of cancer treated by oncologists. Treatment options for lung cancer include surgery, chemotherapy, radiation therapy, and targeted therapy. The lung cancer market is a rapidly growing segment of the oncology market. It is driven by the increasing prevalence of lung cancer, advances in treatment options, and the increasing availability of targeted therapies. The market is expected to continue to grow in the coming years due to the increasing demand for better treatments and the development of new therapies. Some companies in the lung cancer market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more